Meeting Milestones and Patient Needs Through Expedited Delivery of Phase I Materials

In as little as 14 weeks from receiving your small molecule API, you can have your Phase I drug product manufactured, labelled, packaged and delivered to the clinic. That’s 1 month faster than most standard timelines, and includes a one-month stability study.

Learn how Reneo Pharmaceuticals was able to get to clinic in 14 weeks from delivery of their API with the Quick to Clinic™ for Oral Solid Dose program.